Corporate Pressure, Rising Costs and the CMA Investigation: What Is Happening in the UK Vet Industry?

Analysis & rewrite by The Veterinary News & Views — January 2026

Over the past decade, the United Kingdom’s small-animal veterinary sector has undergone a profound structural change. Independent practices have been rapidly acquired by large corporate groups, prices for treatment have risen sharply, and both pet owners and veterinary professionals are asking whether commercial pressures are beginning to compromise trust in clinical decision-making.

According to data highlighted in the BBC report and in the provisional findings of the UK’s Competition and Markets Authority (CMA), prices charged by vet practices in the UK increased by around 63% between 2016 and 2023. During the same period, the market has become heavily consolidated: six large veterinary groups now control an estimated 60% of the UK pet-care market. These two trends — rising prices and growing corporate concentration — are at the centre of the CMA’s ongoing investigation into whether pet owners are getting fair value for money.

The CMA’s concerns are not purely theoretical. BBC journalists collected testimonies from dozens of veterinarians who either currently work, or previously worked, inside corporate-owned clinics. Several of them described a growing emphasis on financial targets, including metrics such as revenue per consultation, the number of blood tests or X-rays requested, and the overall value of diagnostic work carried out per patient. In some cases, clinics were reportedly colour-ranked in internal dashboards, with the top-earning practices appearing in green and the lowest quartile in red.

While such performance frameworks are often presented as tools to improve “clinical standards” or “consistency of care”, the vets interviewed by the BBC expressed deep unease. They warned that when the number of blood tests, X-rays or ultrasound scans is monitored alongside financial targets, the subtle pressure to “do more” can begin to clash with a vet’s duty to make proportionate, evidence-based decisions. In particular, some feared that owners of older or chronically ill animals were being offered expensive diagnostic work-ups where a more conservative, symptom-led approach would also have been clinically acceptable.

For pet owners, the impact of these pressures is most visible in the final bill. The BBC report shared several real-world cases in which families were faced with costs running into thousands of pounds for emergency procedures and repeated diagnostic tests. In one example, an owner reported paying more than five thousand pounds for less than a day of intensive vet care; in another, multiple investigations led to a bill of around thirteen thousand pounds without a clear diagnosis at the end of the process. These stories, while anecdotal, sit against the broader background statistic that UK households together spent £6.3 billion on vet and pet-care services in 2024 alone.

The CMA’s analysis suggests that structural features of the market are partly to blame. The six largest groups — including IVC Evidensia, CVS Group, VetPartners, Medivet, Linnaeus and the Vets for Pets network owned by Pets at Home — have, over time, built extensive regional and national portfolios. Beyond first-opinion clinics, some of these companies also have financial interests in referral hospitals, out-of-hours services, diagnostic laboratories, pet crematoria and online pharmacies. From a regulatory perspective, this raises questions about how freely owners can choose among competing providers when their own vet may be tightly integrated into a vertically aligned corporate chain.

In its provisional report, the CMA estimated that, between 2020 and 2024, the combination of limited competition, opaque ownership structures and patchy price transparency may have cost UK pet owners up to £900 million. This figure refers not to fraud or malpractice, but to the economic cost of a market that is not working as efficiently as it could: if owners do not know who ultimately owns their local practice, or what alternative providers might charge, they cannot easily shop around or challenge high bills.

Corporate groups firmly reject the idea that they put profits ahead of animal welfare. The BBC report quotes statements from major players who insist that their vets retain full clinical independence and that their data systems are designed to close gaps in care, not to encourage unnecessary procedures. They also point to rising medicine prices, increased investment in facilities and staff shortages as important drivers of higher fees. At the same time, consumer research cited by the CMA shows an interesting contrast: while owners are generally satisfied with the clinical care their pets receive, they are significantly less satisfied with the cost of that care and with how clearly those costs are explained in advance.

The CMA is expected to publish its final recommendations in 2026. Possible outcomes include stricter rules on price display, clearer disclosure of who owns each practice, and more explicit communication about corporate links between local clinics, emergency hospitals and ancillary services such as cremation or online pharmacy businesses. The aim is not to punish veterinary professionals, but to improve competition and give pet owners the information they need to choose the right provider, the right level of treatment and the right way to purchase medicines without unnecessary financial strain.

As Pakistan’s veterinary sector continues to expand—with rapid growth in private clinics, diagnostic labs, pet pharmacies and modern animal hospitals—the UK experience serves as a timely reminder of the challenges that can emerge in fast-growing markets. Pakistan has not yet reached the level of corporate consolidation seen in the UK, but increasing investment and the rising commercial value of veterinary services signal that similar dynamics may develop in the coming years. This makes it essential for policymakers, regulators and professional bodies to establish early safeguards around price transparency, clinical independence and service standards, ensuring that the sector’s modernization benefits both animal welfare and the financial security of the families who depend on these services.?

The Veterinary News & Views will continue to follow the CMA investigation and subsequent reforms, not only as a matter of international interest but also as a benchmark for best practices in policy, pricing transparency and professional independence in the wider veterinary world.

References:
BBC News, “Vets under corporate pressure to increase revenue” (2026); Competition and Markets Authority (CMA) – Provisional Market Study on UK Vet Services; Analysis and editorial adaptation by The Veterinary News & Views.